Reportlinker.com

Reportlinker.com

September 10, 2008 12:02 ET

Examine the World Proteomics Market

LONDON, UNITED KINGDOM--(Marketwire - Sept. 10, 2008) - Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.

World Proteomics Market

http://www.reportlinker.com/p092466/World-Proteomics--Market.html

This report analyzes the worldwide markets for Proteomics in Millions of US$. The major Product segments analyzed are Expression Proteomics, Functional Proteomics, and Structural Proteomics.The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2015. The report profiles 170 companies including many key and niche players worldwide such as Agilent Technologies, Inc., Applied Biosystems, Bio-Rad Laboratories, Inc., Dionex Corporation, GE Healthcare, Biacore Life Sciences, Invitrogen Corporation, PerkinElmer, Inc., Proteome Systems Ltd., Shimadzu Biotech, and Thermo Fisher Scientific. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.


PROTEOMICS MCP-1029
A GLOBAL STRATEGIC BUSINESS REPORT

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-2
Product Definitions and Scope of Study I-3
Expression Proteomics I-3
Functional Proteomics I-3
Structural Proteomics I-4


II. EXECUTIVE SUMMARY

1. Global Market Overview II-1
Current Spotlight II-1
Genesis of Proteomics II-1
Tales From Times Gone By II-2
Proteomics: A Critical Drug Discovery Tool II-2
Factors Influencing the Market II-3
Market Drivers II-3
Factors Limiting Market Growth II-4
Major Challenges II-4
Proteomics Sample Preparation Market II-4
Protein Chemistry and its Complexities II-4
Integration of Data & Equipment II-4
Data Validation - A Burning Issue II-4
Standardization & Consistency- A Prime Concern II-5

2. Industry Competition II-6
Industry Participants II-6
Proteomics Market Worldwide: Competitive Landscape II-6
Proteomics Supplier Market II-6
Challenges Ahead II-7
Designing a Novel Business Model II-7

3. Product and Technology Overview II-9
Proteins, Proteome and Proteomics !!!- What are They? II-9
Proteomics - An Introduction II-9
Components of Proteomics II-10
Expression Proteomics II-10
Functional Proteomics II-10
Cell-map Proteomics II-10
Structural Proteomics II-10
Technologies and Proteomics II-10
Proteomics and Genomics II-11
Proteomics and Genomics: A Comparison II-11
Protein Production Pathway: From Gene Expression to
Functional Protein with Controls II-11
From Genomics to Proteomics II-12
Functional Genomics and Proteomics II-12
Push From Genomic Information II-13
Standard Proteomics Approach II-13
Sample Preparation- Step I II-13
Protein Separation-Step II II-14
Protein Visualization II-14
Protein Expression Analysis-Step III II-14
Protein Identification -Step IV II-15
Data Storage and Processing-Step V II-15

4. Overview of Proteomics Technologies II-16
A Snapshot of Various Proteomics Tools II-16
An Insight into Various Proteomics Technologies and their
Application Areas II-16
Protein Separation II-16
Table 1: Worldwide Protein Separation Market (2003-2008P):
Market Share of Leading Players- Applied Biosystems, Waters
Corp., Amersham Biosciences, Agilent Technologies Inc.,
Bio-Rad/ Micromass, Thermo Electron, and Others (Includes
corresponding Graph/Chart) II-17
2-Dimensional Gel Electrophoresis (2DGE) II-17
Protein Characterization II-19
Analysis of Protein Through Mass Spectrometry II-19
MS and Proteins II-19
Y2H, Yeast 2-Hybrid System II-21
Protein Microarrays II-22
Chip Technology II-22
Microfluidic Applications II-23
Role of Bioinformatics in Proteomics II-23
Bioinformatics Applications and Tools in Proteomics II-23
Emerging Proteomics Technologies II-25
MudPIT II-25
ICAT II-25
Phage Display Technique II-26
Advanced Proteomics Technologies: Structural Analysis Tools II-26
X-ray Crystallography II-26
Nuclear Magnetic Resonance (NMR) II-26
In silico Modelling II-27
Physicochemical Factors Constraining Metabolic Functions II-27

5. End-Use Application Areas II-28
Proteomics in Drug and Diagnostic Discovery II-29
Proteomics and Drug Discovery II-29
Proteomic Approaches Gaining Prominence in Cancer Drug
Discovery II-30
Leading Companies in Proteomics-Based Drug Discovery II-31
Future of Proteomics in Drug Discovery II-31

6. New Product Solutions/Developments II-32
Bruker Daltonics Introduces Advanced ETD II Module II-32
Applied Biosystems Expands its iTRAQ(R) Line of Labeling Reagents II-32
PerkinElmer Expands Its Imaging Technologies and Protein
Analysis Product Portfolio II-32
Sigma-Aldrich Introduces new Proteomics Dynamic Range Standard II-33
Thermo Fisher Scientific Expands Mass Spectrometry Portfolio II-33
Bruker Daltonics Launches New Versions of Compass(TM) and
ProteinScape(TM) Softwares II-33
Applied Biosystems and Sciex Roll Out New Proteomic Tools II-34
Bruker Daltonics Rolls Out New Compass(TM) 1.2 Software II-34
Bruker Daltonics Unveils New Mass Spectrometer, apex(R)-ultra FTMS II-34
Thermo Fisher Unveils the Latest LTQ XL mass spectrometer II-34
Genedata Introduces Genedata Expressionist(R) Pro 3.0 II-35
Biozentrum to Employ GeneBio's Phenyx as Primary Search Engine II-35
Shimadzu Biotech Unveils AXIMA-TOF2 II-35
Waters Corporation Unveils Latest Columns for Peptide Analysis
and Isolation II-36
Applied Biosystems and MDS Sciex Unveil QSTAR(R) Elite LC/MS/MS
System II-36
Waters Corporation to Roll out Updated ProteinLynx Global
SERVER(TM) Version II-36
Syngene Unveils the Latest Integrated Proteomics Products II-37
Sigma Unveils the Latest ProteoPrep 20 Plasma Immunodepletion Kit II-37
Sigma-Aldrich Introduces First Commercial Proteomics Standard II-37
Bruker Daltonics and Serva Electrophoresis Unveil ICPL Triplex
kit II-38
Agilent Unveils 3100 OFFGEL Fractionator II-38
Agilent Technologies Unveils Multiple Affinity Removal System 7 II-38
Bio-Rad Unveils Proteon XPR36 Protein Interaction Array System II-39
Sigma-Aldrich Adds Panorama Human Kinase v1 Array to Extend
Panorama Protein Array Line II-39
PerkinElmer Expands Proteomic Research Tools Offering II-39
Waters Launches Advanced Version of Proteomics Research Software II-39
Lumera to Develop New Protein Biochip in Collaboration with HMS II-40
Agilent Launches Ion Trap Mass Spectrometer, LC/MSD Trap XCT
Ultra II-40
Bruker Launches Novel Mass Spectrometer System, HCTultra II-40
Bruker Launches Novel Post-Translational Protein Technique II-40
Kinexus Launches New Functional Proteomic Database II-41
Applied Biosystems Launches Series of Liquid Chromatography
Systems II-41
Pall Introduces Three Novel Protein Purification Kits II-41
Ciphergen Launches Nex-Gen ProteinChip System, Series 4000 II-41
Ciphergen Introduces Protein Software in Collaboration with
Salford II-41
Bruker Launches New Proteomics RIMS II-42
Invitrogen Launches High-Density Protein Microarray II-42
Amersham Biosciences Introduces Improved 2-D Software II-42
Proteome Introduces Latest Version of Proteomic Software
Solutions II-42
Proteome Systems Introduces Intelligent Electrophoresis Solutions II-42
Applied Biosystems Develops 4700 System II-43
Biacore Launches Functional Proteomics System II-43
Biacore Launches Software and Sensor Chips II-43
Biacore Launches Procel(TM) II-43
Agilent Introduces Dual Loop Autosampler for HPLC Purification II-43
Agilent Introduces New Methods for RNAi II-43
Agilent Introduces Human 1B Oligo Microarray Kit II-44
Agilent Introduces New Seperation System II-44
Agilent Introduces Nano-flow LC System II-44
Ciphergen Launches IDM Platform II-44
Dionex Releases Monolithic Capillary Columns II-44
Beckman Enhances the Product Line of ProteomeLab II-44

7. Recent Industry Activity II-45
Sigma-Aldrich Enters an Exclusive Alliance with Atlas
Antibodies to Distribute New Prestige Antibodies(TM) II-45
Nonlinear Dynamics Inks Distribution Agreement with UVP, LLC II-45
Plexera Enters into an Access Agreement with Auguron for NAPPA II-45
NextGen and Paragon Bioservices Enter into a Commercial
Partnership Agreement II-45
Digilab Acquires Genomic Solutions and MAIA Scientific from
Harvard Bioscience II-46
Power3 Ropes in FAH to Distribute its BC-SeraPro(TM) in the
Middle East II-46
Thallion Sells Majority Stake to US-based Private Equity
Firm, Great Point Partners II-46
Ecopia and Caprion Merge to Form Thallion Pharmaceuticals II-46
BG Medicine and Applied Biosystems Collaborate for Biomarker
Discovery and Development II-47
Bio-Rad Acquires Ciphergen's Proteomics Instrument Business II-47
BioMachines Establishes New Proteomics Services Unit II-47
GE Acquires Biacore II-47
Fuji Film Acquires Minority Stake in Perseus II-48
Cenix BioScience, Applied Biosystems, and Biotec of the
Technische Universitat Dresden Collaborate II-48
GeneBio and Goodlett Enter into Collaboration II-48
Genetix Group to Acquire Applied Imaging II-49
Massively Parallel Technologies Signs a Deal with University
of Colorado II-49
Genospectra Plans Merger with Panomics II-49
PerkinElmer Announces Acquisition of Proteomics Labeling
Technology II-50
ActivX Biosciences Extends Alliance with Pfizer II-50
Invitrogen Acquires Zymed II-50
FALCO Signs a Collaborative Agreement with PPD II-50
Invitrogen Acquires BioSource International II-50
Agilix and Protana Enters into a Licensing Agreement II-50
Invitrogen Pacts Marketing Agreement with Applied Biosystems II-51
Waters Corp. Pacts a Technical Collaboration with Matrix II-51
Kyorin Acquires ActivX Biosciences II-51
Bruker Signs Marketing Agreement with Serva Electrophoresis II-51
PerkinElmer Enters into a Marketing Agreement with NLD II-51
Pepscan Collaborates with Cytos Biotechnology . II-52
BD Acquires Protein Separation Technology of FFE Weber II-52
Invitrogen Acquires Caltag Laboratories II-52
Qiagen Acquires Major Assets of LumiCyte II-52
LifeSpan BioSciences Inks Long-Term Agreement with Pfizer II-52
Dana-Farber Cancer Institute To Establish Proteomics Research
Center II-53
Bruker, University of Goettingen and PANATecs Signs an
Development Agreement II-53
NextGen Sciences Partners with Protagen II-53
GeneBio Collaborates with Genedata II-53
Sage-N Research to Establish R&D Center in China II-53
Sage-N Research Integrates Sorcerer(TM) Systems with TPP analysis
Platform of ISB II-54
Agilent Introduces Whole Human Genome Microarray II-54
Invitrogen Acquires Protometrix II-54
Nanogen Acquires SXP II-54
BioCrossroads Establishes INCAPS, Protein Center of Excellence II-54
Ciphergen Acquires Remaining Stake in Ciphergen Biosystems K.K. II-55
Shimadzu Inks OEM Agreement with Nonlinear Dynamics II-55
Whatman Acquires Schleicher & Schuell II-55
GE Healthcare Acquires Amersham Plc II-55
GeneProt Extends Collaborative Agreement with Novartis II-55
GeneProt Collaborates with Lundbeck to Conduct CNS Proteomics
Study II-56

8. Focus on Select Key Players II-57
Agilent Technologies, Inc. (USA) II-57
Applied Biosystems (USA) II-57
Bio-Rad Laboratories, Inc. II-57
Dionex Corporation (USA) II-58
GE Healthcare (United Kingdom) II-58
Biacore Life Sciences II-58
Invitrogen Corporation (USA) II-58
PerkinElmer, Inc. (USA) II-59
Proteome Systems Ltd. (Australia) II-59
Shimadzu Biotech (Japan) II-59
Thermo Fisher Scientific (USA) II-60

9. Global Market Perspective II-61
Table 2: World Recent Past, Current & Future Analysis for
Proteomics by Geographic Region - US, Canada, Japan, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2003 through 2010
(Includes corresponding Graph/Chart) II-61

Table 3: World Long-term Projections for Proteomics by
Geographic Region - US, Canada, Japan, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2011 through 2015 (Includes
corresponding Graph/Chart) II-62

Table 4: World 10-Year Perspective for Proteomics by
Geographic Region/Country - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe and Rest of World Markets
for Years 2003, 2008 and 2012 (Includes corresponding
Graph/Chart) II-62

Table 5: World Recent Past, Current & Future Analysis for
Proteomics by Product Segment - Expression Proteomics,
Functional Proteomics and Structural Proteomics Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2010 (Includes corresponding
Graph/Chart) II-63

Table 6: World Long-term Projections for Proteomics by Product
Segment - Expression Proteomics, Functional Proteomics and
Structural Proteomics Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2011 through
2015 (Includes corresponding Graph/Chart) II-63

Table 7: World 10-Year Perspective for Proteomics by Product
Segment - Percentage Breakdown of Dollar Sales for Expression
Proteomics, Functional Proteomics and Structural Proteomics
Markets for Years 2003, 2008 and 2012 (Includes corresponding
Graph/Chart) II-64

10. Glossary of Terms II-65
1-D, 2-D, 3-D II-65
Atmospheric Pressure Ionisation II-65
Electrophoresis II-65
Functional Genomics II-65
High-Throughput II-65
Liquid Chromatography (LC) II-65
Mass Spectrometry (MS) II-65
Matrix-Assisted Laser Desorption Ionisation (MALDI) II-65
Nuclear Magnetic Resonance II-66
X-ray Diffraction II-66
Yeast Two-Hybrid System II-66
2D-PAGE (Two-dimensional PolyAcrylamide Gel Electrophoresis) II-66
TOF (Time of Flight) II-66
Quadrupole II-66
Q-TOF (Quadrupole Time of Flight) II-66
ESI (Electrospray Ionisation) II-66


III. MARKET

1. The United States III-1
A. Market Analysis III-1
Proteomics Sample Preparation Market III-1
Table 8: US Proteomics Market (2004): Market Share of
Leading Players in Proteomics Sample Preparation Markets
-GE Healthcare, Agilent Technologies,, Millipore
Corporation, Bio-Rad Laboratories, Inc., Invitrogen Corp.,
Sigma-Aldrich Co and Others (Ranked by Breakdown of
Revenues) (Includes corresponding Graph/Chart) III-2
Proteomics Arrays Markets III-2
Table 9: US Proteomics Market (2005): Market Share of
Leading Players in Proteomics Array Segment- Bio-Rad
Laboratories, Invitrogen Corporation, and Others (Includes
corresponding Graph/Chart) III-2
Product Launches/Developments III-2
Strategic Corporate Developments III-13
Focus on Select Players III-21
ActivX Biosciences, Inc. III-21
Adnexus III-22
Agilent Technologies Inc. III-22
Applied Biosystems III-22
Bio-Rad Laboratories, Inc. III-23
Bruker Daltonics, Inc. III-23
Caliper Life Sciences III-23
Digilab Genomic Solutions, Inc. III-24
Dionex Corporation III-24
Human Genome Sciences, Inc. III-24
Invitrogen Corporation III-25
Millipore Corp. III-25
PerkinElmer, Inc. III-25
Thermo Fisher Scientific III-26
Waters Corp. III-26
Xencor,Inc. III-26
Zyomyx, Inc. III-27
B. Market Analytics III-27
Table 10: US Recent Past, Current & Future Analysis for
Proteomics Market Independently Analyzed with Annual Sales
in US$ Million for Years 2003 through 2010 (Includes
corresponding Graph/Chart) III-27

Table 11: US Long-term Projections for Proteomics Market
Independently Analyzed with Annual Sales in US$ Million for
Years 2011 through 2015 (Includes corresponding
Graph/Chart) III-28

2. Canada III-29
A. Market Analysis III-29
Research Funding III-29
Product Launches III-29
Strategic Corporate Developments III-30
Key Player III-30
Caprion Proteomics, Inc. III-30
B. Market Analytics III-31
Table 12: Canadian Recent Past, Current & Future Analysis
for Proteomics Market Independently Analyzed with Annual
Sales in US$ Million for Years 2003 through 2010 (Includes
corresponding Graph/Chart) III-31

Table 13: Canadian Long-term Projections for Proteomics
Market Independently Analyzed with Annual Sales in US$
Million for Years 2011 through 2015 (Includes
corresponding Graph/Chart) III-31

3. Japan III-32
A. Market Analysis III-32
Strategic Corporate Developments III-32
Shimadzu Biotech - A Key Player III-33
B. Market Analytics III-34
Table 14: Japanese Recent Past, Current & Future Analysis
for Proteomics Market Independently Analyzed with Annual
Sales in US$ Million for Years 2003 through 2010 (Includes
corresponding Graph/Chart) III-34

Table 15: JapaneseLong-term Projections for Proteomics
Market Independently Analyzed with Annual Sales in US$
Million for Years 2011 through 2015 (Includes corresponding
Graph/Chart) III-34

4. Europe III-35
A. Market Analysis III-35
Europe on the Fast Track III-35
Table 16: European Proteomics Market (2007): Percentage
Breakdown of Deployment of Proteomics Technologies in
End-Use Segment- Research and Academia Institutions,
Pharmaceutical Companies and Clinical Laboratories
(Includes corresponding Graph/Chart) III-35
B. Market Analytics III-36
Table 17: European Recent Past, Current & Future Analysis
for Proteomics by Geographic Region/Country- France,
Germany, UK and Rest of Europe Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2003
through 2010 (Includes corresponding Graph/Chart) III-36

Table 18: European Long-term Projections for Proteomics by
Geographic Region/Country- France, Germany, UK and Rest of
Europe Markets Independently Analyzed with Annual Sales in
US$ Million for Years 2011 through 2015 (Includes
corresponding Graph/Chart) III-36

Table 19: European 10-Year Perspective for Proteomics by
Geographic Region/Country - Percentage Breakdown of Dollar
Sales for France, Germany, UK and Rest of Europe Markets for
Years 2003, 2008 and 2012 (Includes corresponding
Graph/Chart) III-37

4a. France III-38
A. Market Analysis III-38
Key Player Review III-38
Hybrigenics SA III-38
B. Market Analytics III-39
Table 20: French Recent Past, Current & Future Analysis for
Proteomics Market Independently Analyzed with Annual Sales
in US$ Million for Years 2003 through 2010 (Includes
corresponding Graph/Chart) III-39

Table 21: French Long-term Projections for Proteomics Market
Independently Analyzed with Annual Sales in US$ Million for
Years 2011 through 2015 (Includes corresponding
Graph/Chart) III-39

4b. Germany III-40
A. Market Analysis III-40
Outlook III-40
Strategic Corporate Developments III-40
B. Market Analytics III-42
Table 22: German Recent Past, Current & Future Analysis for
Proteomics Market Independently Analyzed with Annual Sales
in US$ Million fo Years 2003 through 2010 (Includes
corresponding Graph/Chart) III-42

Table 23: German Long-term Projections for Proteomics Market
Independently Analyzed with Annual Sales in US$ Million for
Years 2011 through 2015 (Includes corresponding Graph/Chart) III-43

4c. The United Kingdom III-44
A. Market Analysis III-44
Current Trends in the UK Market for Proteomics III-44
Highlights III-44
Product Launches III-44
Strategic Corporate Developments III-45
B. Market Analytics III-47
Table 24: United Kingdom Recent Past, Current & Future
Analysis for Proteomics Market Independently Analyzed with
Annual Sales in US$ Million fo Years 2003 through 2010
(Includes corresponding Graph/Chart) III-47

Table 25: United Kingdom Long-term Projections for
Proteomics Market Independently Analyzed with Annual Sales
in US$ Million for Years 2011 through 2015 (Includes
corresponding Graph/Chart) III-48

4d. Rest of Europe III-49
A. Market Analysis III-49
Switzerland III-49
Portugal III-49
Strategic Corporate Developments III-49
Key Players III-51
Biacore Life Sciences III-51
Geneva Bioinformatics S.A. (Switzerland) III-51
B. Market Analytics III-52
Table 26: Rest of Europe Recent Past, Current & Future
Analysis for Proteomics Market Independently Analyzed with
Annual Sales in US$ Million for Years 2003 through 2010
(Includes corresponding Graph/Chart) III-52

Table 27: Rest of Europe Long-term Projections for
Proteomics Market Independently Analyzed with Annual Sales
in US$ Million for Years 2011 through 2015 (Includes
corresponding Graph/Chart) III-52

5. Rest of World III-53
A. Market Analysis III-53
Outlook III-53
Australia III-53
India III-53
Indian Scientific Research towards Functional Genomics and
Proteomics III-53
Strategic Corporate Developments III-54
Key Player III-54
Proteome Systems Ltd. (Australia) III-54
B. Market Analytics III-55
Table 28: Rest of World Recent Past, Current & Future
Analysis for Proteomics Market Independently Analyzed with
Annual Sales in US$ Million for Years 2003 through 2010
(Includes corresponding Graph/Chart) III-55

Table 29: Rest of World Long-term Projections for Proteomics
Market Independently Analyzed with Annual Sales in US$
Million for Years 2011 through 2015 (Includes corresponding
Graph/Chart) III-55

IV. COMPETITIVE LANDSCAPE

To order this report:

World Proteomics Market

http://www.reportlinker.com/p092466/World-Proteomics--Market.html

More market research reports here!

Contact Information